62107289 Advances in Feline Neurology (1)

download 62107289 Advances in Feline Neurology (1)

of 8

Transcript of 62107289 Advances in Feline Neurology (1)

  • 8/3/2019 62107289 Advances in Feline Neurology (1)

    1/8

    88

    Advances in Feline Neurology

    Philip A. March, DVM, MSDiplomate ACVIM (Neurology)

    Assistant Professor

    Department of Veterinary Clinical Sciences

    College of Veterinary MedicineThe Ohio State University

    Columbus, Ohio 43210

    KEY WORDS neurologic examination

    meningoencephalomyelitis

    myasthenia gravis

    epilepsy

    meningioma

    Neurologic disorders in the cat are a diagnostic and

    therapeutic challenge. The inherent difficulties in per-

    forming a thorough neurologic examination in cats

    and the atypical signs sometimes exhibited by cats

    make neurolocalization of lesions difficult. Cats also

    are not susceptible to the same types of diseases as

    dogs. Specifically, idiopathic inflammatory disorders,

    such as granulomatous meningoencephalomyelitis

    (GME), idiopathic meningitis disorders, polyradicu-

    loneuritis, and polymyositis, are rare in the cat. Infec-

    tious, neoplastic, and vascular diseases are common in

    cats and can affect the nervous system focally or multi-

    focally. Because underlying diseases are common, itis advisable to approach both the diagnosis and treat-

    ment of feline neurologic disorders aggressively. This

    paper addresses some important differences in the di-

    agnosis and treatment of neurologic problems in the

    cat compared to the dog. Selected disorders that pref-

    erentially affect different areas of the nervous system

    are discussed from the standpoint of their usual pre-

    sentation, tests now being used for definitive diagno-

    sis, and therapeutic modalities currently available for

    each condition.

    DIAGNOSTIC AIDSThe Neurologic Examination

    Stress and the sympathetic overdrive that many cats

    experience during the neurologic examination mask

    certain deficits, create new ones, and generally

    complicate the practitioners ability to neurolocalize

    the lesion. It is rare to be able to perform a thorough

    examination on cats unless the patient is extremely

    cooperative or is dull or obtunded because of the un-

    derlying disease. Certain reflex and response tests in

    cats are more reliable and not as subject to environ-

    mental stress. Even these tests may be difficult to per-

    form in an excited, apprehensive cat unless the exam-

    iner maintains some patience and minimizes restraint

    during the examination.

    Certain neurologic examination tests in alert,

    nonobtunded cats are frequently unreliable. These in-clude the knuckling tests for conscious proprioception

    and myotactic limb reflexes. Hopping, hemihopping,

    and tactile placing are more reliable tests of postural

    control in cats. The flexor withdrawal reflex is the

    most reliable limb reflex in cats, and close attention to

    the strength of the withdrawal and the participation of

    all muscle groups in this reflex can be very helpful in

    determining whether a peripheral or a lower motor

    neuron (LMN) disorder is present. Observing for a

    crossed extensor (abnormal extension of the opposite

    limb) during the flexor reflex is important as well.

    Presence of a crossed extensor is indicative of an up-per motor neuron (UMN) lesion (brain or spinal cord).

    Gait analysis is also difficult in cats that refuse to

    move because of either fright or imbalance. Placing

    the cat in an empty, quiet room or observing ambula-

    tion in a cage may be helpful techniques. Wheelbarrow-

    ing, hopping, placing tests, and gently coaxing the pa-

    tient to jump from an elevated surface to the floor are

    used to assess strength and coordination. Because

    some cats do not menace because of fear and in-

    creased sympathetic tone, dropping cotton balls or us-

    ing the visual placing test may be a better test of vi-

    sion. The dolls eye reflex in cats is best accomplished

    by holding the cat in the examiners hands and rotat-

    ing the cat around the examiner.

    In the final analysis, there is no substitute for a de-

    tailed description of neurologic signs that were evi-

    dent to the owner in the home environment. Questions

    concerning abnormal behavior, seizurelike activity,

    sleep-wake cycles, circling tendencies, stumbling,

    falling, incoordination, reluctance to jump, bumping

    into objects, etc., should be asked. The speed of onset

    and progression of clinical signs are likewise critical

    pieces of information. A videotape of episodic eventscan provide extremely valuable information.

    Approach to Diagnostic TestingAs discussed in the previous section, an aggressive

    diagnostic approach to a cat with neurologic signs is

    often warranted. Infectious, neoplastic, and vascular

    disorders can affect multiple body systems, so a com-

    plete blood count, chemistry profile, urinalysis, feline

    immunodeficiency virus (FIV) and feline leukemia

    virus (FeLV) testing, and thoracic radiographs are rec-

    ommended if neurologic signs are present. Hepatic

  • 8/3/2019 62107289 Advances in Feline Neurology (1)

    2/8

    alanine aminotransferase (ALT) elevations may be

    found in cats with feline infectious peritonitis (FIP

    dry form), toxoplasmosis, and hyperthyroidism, all

    diseases with potential nervous system involvement.

    Central nervous system (CNS) lymphosarcoma is

    strongly associated with nonregenerative anemia and

    positive FeLV status.1 In older cats, a T4 level andblood pressure measurements are indicated, especially

    if forebrain signs are present.

    A complete ophthalmic examination is recommend-

    ed in feline patients with nervous system disease.

    Cryptococcosis, toxoplasmosis, and FIP are common

    causes of anterior and posterior uveitis. Systemic

    hypertension may lead to spontaneous hemorrhage in

    both the retina and the CNS. Papilledema may be ob-

    served in cats with brain tumors and elevated intra-

    cranial pressure. Horners syndrome is relatively more

    common in cats than in dogs and pharmacologic test-

    ing may be indicated to determine whether the lesionis postganglionic (common cause is a middle/inner ear

    disease) or preganglionic (common cause is a cranial

    mediastinal mass).

    Serology is a critical component of the diagnostic

    workup. This is especially important in cats with any

    outdoor history or exposure to multiple cats in a

    household (catteries, etc.). There are, however, report-

    ed cases of cryptococcosis in strictly indoor cats with

    no exposure to other cats. The latex agglutination

    antigen test is the current test of choice for diagnosis

    of Cryptococcus neoformans.24 Paired serum titers

    (23 weeks apart) are strongly recommended for diag-

    nosis of toxoplasmosis. Coronavirus titers are recom-

    mended by this author if signs of FIP are present.

    False-negative and false-positive results are possi-

    ble,57 but a very high titer in conjunction with typical

    clinical signs (fever, uveitis, central vestibular

    signs/seizures) is highly suggestive of infection.

    Cerebrospinal fluid (CSF) cytology and titers are in-

    dicated in certain circumstances. Multifocal signs or

    focal signs present in conjunction with a high suspi-

    cion of infectious diseases are indications for CSF

    analysis. CSF cytology should be performed within 1hour of collection by a laboratory that has cell count-

    ing abilities and a cytocentrifuge. Local human hospi-

    tal laboratories may be willing to perform this service

    and have been very approachable in this authors ex-

    perience. The usual delay in processing that occurs

    with most veterinary courier services results in cell ly-

    sis and a nondiagnostic sample. Colorado State Uni-

    versity Veterinary Diagnostic Laboratory performs a

    variety of antigen and antibody tests on CSF (includ-

    ing tests for cryptococcosis and toxoplasmosis). If

    serum is also submitted in conjunction with CSF, this

    laboratory will also determine whether intrathecal

    antibody is present (a definitive test for CNS infec-

    tion). In some cases, serum titers may not reflect what

    is occurring in the CNS. Furthermore, cases of CNS

    cryptococcosis with negative serum titers have been

    reported.8

    Imaging is usually indicated if a focal lesion is sus-pected. Examples include focal lesions of the fore-

    brain, brain stem, or spinal cord. Skull radiographs

    may be useful in cases of craniocerebral trauma or if a

    meningioma is suspected (look for areas of focal hy-

    perostosis or lysis/thinning of the calvarium). Bulla

    radiographs are indicated in cases of middle/inner ear

    disease (otitis, neoplasia). Computed tomography

    (CT) is a sensitive imaging modality for middle/inner

    ear disease in the cat. Plain spinal radiographs and

    myelography are sometimes useful, but high-quality

    magnetic resonance imaging (MRI) of the spinal cord

    is the most sensitive means of detecting intramedullarylesions in cats. MRI is also the diagnostic test of

    choice for imaging of intracranial neoplastic masses

    in cats. Because of the expense of MRI, it is usually

    performed if owners are interested in surgery and/or

    radiation therapy for their pet.

    Electrodiagnostic testing is used most frequently in

    cases of motor unit (peripheral nervous system) dis-

    ease. Electromyography (EMG), nerve conduction

    tests, and repetitive nerve stimulation are commonly

    used in the cat to help localize a lesion to nerve, mus-

    cle, or neuromuscular junction. Muscle and/or nerve

    biopsies are indicated if EMG and nerve conduction

    tests are abnormal.

    SELECTED DISORDERSDiseases of the Forebrain

    Lesions of the forebrain in cats typically cause signs

    of behavior change, seizures, circling or body turn to-

    ward the side of the lesion, contralateral visual

    deficits, and contralateral postural deficits (slow hop-

    ping reactions). Any or all these signs may be present.

    Head trauma, infectious agents (FIP, toxoplasmosis,

    cryptococcosis), feline ischemic encephalopathy (FIE)and other vascular disorders, and neoplastic diseases

    may cause forebrain signs in cats.

    FIE refers to a condition of unilateral cerebro-

    cortical infarction due to vasospasm and/or occlusion

    of the middle cerebral artery. Typical signs of FIE in-

    clude a peracute onset of circling, behavior change,

    visual deficits, and seizures. In some cases, seizures

    may be the only sign observed.9,10 Recently, FIE has

    been associated with aberrant migration ofCuterebra

    spp. larvae in the cat brain.10 This finding may relate

    to the high incidence of FIE in the late summer and

    ADVANCES IN FELINE NEUROLOGY 89

  • 8/3/2019 62107289 Advances in Feline Neurology (1)

    3/8

    90 PROCEEDINGS OF THE 23rd WALTHAM/OSU SYMPOSIUM

    early fall, times of the year when Cuterebra spp. are

    most prevalent in the environment.

    The most common cause of forebrain signs in older

    cats is neoplasia. Among primary brain tumors, feline

    meningiomas are by far the most common tumors

    found and are also a frequent cause of seizures in this

    age group. The signs, diagnosis, and treatment of fe-line meningiomas are discussed next.

    MeningiomasFeline meningiomas may arise from meninges (the

    arachnoid layer) covering the cerebral cortex, brain

    stem, falx and tentorium, or tela choroidea of the third

    ventricle. The most common site of involvement is

    the external surface of the cerebral cortex.11,12 As the

    tumor grows and expands, adjacent brain tissue is

    slowly compressed but rarely invaded directly by neo-

    plastic cells. The brain has an enormous capacity to

    compensate for slowly compressive lesions, which iswhy signs may be so insidious in onset. In many cases,

    the signs reported by owners are subtle and include

    mild lethargy, decreased appetite, decreased respon-

    siveness, and pacing. Seizures (partial or generalized)

    may be the only sign observed. A thorough neurologic

    examination may uncover contralateral postural and

    visual field deficits. It is not uncommon for large,

    space-occupying meningiomas to cause positional

    nystagmus. This is probably due to elevated intra-

    cranial pressure and early forebrain herniation with

    brain stem compression.11,12 MRI is the diagnostic test

    of choice to image the tumor and also can be used to

    plan an eventual surgical approach.

    Signs are initially prednisone responsive for many

    weeks, until the tumor reaches a critical volume. If

    signs of early herniation are present, mannitol therapy

    (1 g/kg IV over 20 minutes) may be required to stabi-

    lize the patient. The treatment of choice is surgical re-

    section. The tumor often shells out because it is so

    well encapsulated. Recurrence may or may not occur

    in months to years. In one study, 6 out of 10 cats that

    underwent surgical meningioma resection lived for

    longer than 2 years postsurgery.13

    Antiepileptic drug(AED) therapy is often required postoperatively to

    control seizures.

    Idiopathic EpilepsyPrimary or inherited epilepsy, as found in many ca-

    nine breeds, is not commonly recognized in cats.

    Some feline patients with epilepsy are classified as

    idiopathic when no obvious lesions are found

    through antemortem diagnostic tests (including CSF

    analysis, MRI, etc.). It is important to realize that pre-

    vious insults (traumatic, inflammatory, vascular) to

    the brain often leave little evidence of a lesion, even

    on MRI. The insult, however, may leave an area of

    hyperexcitable brain tissue (a seizure focus) that

    leads to a condition of epilepsy (recurrent seizure ac-

    tivity of neural origin).

    Treatment of epilepsy in the cat is similar to treat-

    ment of epilepsy in the dog, but there are some impor-tant differences. Phenobarbital is considered the first

    drug of choice for feline epilepsy. Phenobarbital is

    metabolized at a slower rate in the cat than in the dog,

    and cats are generally more susceptible to the sedative

    effects of the drug. The recommended starting dose is

    2.5 mg/kg daily.14 This dose may need to be increased,

    depending on serum concentrations actually achieved

    and response to therapy. The therapeutic blood con-

    centration in cats is 10 to 30 g/ml, which differs

    from the 15 to 40 g/ml therapeutic range in dogs.

    Steady-state phenobarbital concentrations are attained

    in about 9 days.14 Concurrent administration of drugsthat are highly protein bound, such as sulfonamides

    and aspirin, should be avoided. Potential side effects

    of phenobarbital in the cat are excessive sedation, be-

    havior change, dermatitis, and blood dyscrasias.15

    Hepatotoxicity has been reported with phenobarbital

    therapy in cats, but this author has not observed this

    side effect.

    The pharmacokinetics of potassium bromide (KBr)

    has recently been examined in the cat.16 The dose re-

    quired to achieve blood concentrations in the 100 to

    150 mg/dl range is similar to that used in dogs (30

    mg/kg daily). The half-life of KBr in cats is 10 days,

    which is considerably shorter than that in dogs (2128

    days). This means that steady-state drug concentra-

    tions of bromide in cats are achieved in 7 to 8 weeks.

    Efficacy of KBr in feline epilepsy is still not docu-

    mented, although early reports claim that successful

    seizure control has been achieved in some patients.

    The best way to administer KBr in cats (because of

    their sensitivity to liquid preparations) is as capsules

    containing 50 to 100 mg of active compound per cap-

    sule.15

    Diazepam is an effective oral AED in cats. The rec-ommended dose is quite variable in the literature. This

    author usually starts at 0.5 mg/kg every 8 to 12 hours

    and increases the dose in increments if satisfactory

    seizure control is not achieved. A recent report of ful-

    minant hepatotoxicity in a small number of cats has

    caused diazepam to fall out of favor as a first-line

    AED.17 Careful monitoring of ALT after 1 week and

    again after 1 month of therapy usually detects this id-

    iosyncratic drug reaction.

    Clorazepate has been used by the Neurology Ser-

    vice at The Ohio State University Veterinary Hospital

  • 8/3/2019 62107289 Advances in Feline Neurology (1)

    4/8

    as a long-term AED in several epileptic cats. This

    AED is especially useful for persistent partial seizures

    in cats.14 The recommended dose is 3.75 to 7 mg per

    cat daily. Rarely, this may need to be increased to atwice daily dosing interval. Excellent seizure control

    in this small population of cats suggests that cloraze-

    pate may be a very effective AED in the feline. See

    Table 1 for a list of the most commonly used AEDs in

    cats.

    Diseases of the Brain StemThe cat brain stem is highly susceptible to a variety

    of disorders. C. neoformans, FIP virus, and Toxoplas-

    ma gondii commonly affect brain stem structures. The

    primary sign of brain stem involvement from any

    cause is a central vestibular syndrome. Head tilt,

    vestibular ataxia, and nystagmus are common features

    of this syndrome. Specific diagnostic and therapeutic

    recommendations for cryptococcosis, toxoplasmosis,

    and FIP are discussed in the next sections.

    CryptococcosisC. neoformans can cause signs of nasal, ocular, and

    nervous system disease in cats. A chronic mucoid

    nasal discharge in conjunction with central vestibular

    signs (ataxia, nystagmus) or seizures should immedi-

    ately raise ones suspicions for this disease. Clinicalsigns of CNS involvement are due to the inflammato-

    ry response to the organism (granulomatous meningo-

    encephalomyelitis) or to a coalescence of large aggre-

    gates of encapsulated organisms, resulting in a mass

    lesion. Signs may be multifocal or focal. Some cats

    may also exhibit weight loss, coughing, subcutaneous

    granulomas around the face and nose, and lym-

    phadenopathy. Serum and/or CSF antigen titers, as

    previously discussed, are highly sensitive and specif-

    ic.2,9,11 CSF analysis usually shows a mixed pleocytosis

    and a mild to moderate elevation in protein. Occasion-

    ally, organisms can be seen in CSF, especially if India

    ink staining is used. Cytology of nasal exudates often

    reveals the organism (512 m in diameter budding

    yeasts with a thick capsule).The treatment of choice is currently fluconazole 50

    mg/cat every 12 hours for a minimum of 2 to 4

    months, although long-term studies of efficacy for

    CNS disease have not been performed on a large pop-

    ulation of cats.24 Itraconazole therapy 10 to 25 mg/kg

    every 24 hours for 4 to 16 months is useful for treat-

    ment of extraneural signs, but its efficacy for CNS in-

    fection has not been adequately studied.3 Traditional-

    ly, cats with CNS cryptococcosis have been given

    poor prognoses for recovery. As newer antifungal

    pharmaceutical agents become available, this outlook

    may change (Table 2).

    In studies of cats infected with Cryptococcus but

    not showing CNS signs, serum antigen titers have

    been followed over time during and after treatment. In

    one study, titers generally decreased during therapy

    and this tended to coincide with clinical improve-

    ment.3 However, positive titers were seen in some re-

    covered cats in another study.4 Although the results

    of the two studies on this subject differ somewhat, it

    appears that some cats retain a positive titer after

    treatment and do not show clinical signs of infection.

    Current recommendations for therapy are to treat 2 to3 months beyond resolution of clinical signs. If titers

    become negative, two negative antigen titers 1 month

    apart are recommended before therapy is discontin-

    ued.3,4

    ToxoplasmosisToxoplasmosis is a very interesting and still not ful-

    ly understood infection of the CNS of cats. Many cats

    previously infected with T. gondii have bradyzoite or-

    ganisms encysted in various tissues, including brain

    and muscle. In most cats, these encysted organisms

    ADVANCES IN FELINE NEUROLOGY 91

    Table 1

    Commonly Used Antiepileptic Drugs in Cats

    Antiepileptic Drug Dose and Dose Interval Approximate Half-Life Time to Steady State Therapeutic Range

    Phenobarbital 2.5 mg/kg PO every 1224 hours IV: 3643 hours 9 days 1030 g/ml

    PO: 58 hours

    Diazepam 0.52 mg/kg PO every 812 hours PO: 1520 hours 45 days (calculated) 0.50.7 g/ml (?)

    (diazepam and metabolites)

    Potassium bromide 30 mg/kg PO every 24 hours or 10 days 78 weeks Not established

    divided every 12 hours

    Clorazepate 3.757 mg PO per cat every 3.6 hours (?) Unknown Unknown

    1224 hours (N-desmethyl-diazepam)

    IV = intravenously; PO = per os.

  • 8/3/2019 62107289 Advances in Feline Neurology (1)

    5/8

    92 PROCEEDINGS OF THE 23rd WALTHAM/OSU SYMPOSIUM

    remain in this latent phase, may produce some chronic

    antigenic stimulation, but are usually incidental.

    Immunocompromising factors (steroid therapy, viral

    infection [FIV or FeLV], stress, neoplasia) appear to

    initiate the recrudescence of these organisms. Dur-

    ing recrudescence, organisms enter a proliferative

    phase and incite an inflammatory response. The in-

    flammatory response can be exuberant, with forma-

    tion of microscopic and macroscopic granulomas.

    Typical signs of multifocal or focal CNS injury in-

    clude seizures (often partial seizures), central vestibu-

    lar signs, cerebellar signs, and, occasionally, cord

    signs.6,9,18 As discussed previously, paired serum titers

    or combination serum/CSF titers are very useful in di-

    agnosing CNS toxoplasmosis. This author prefers touse CSF titers and the IgG index to estimate intrathe-

    cal antibody production. This information combined

    with compatible clinical signs is usually adequate to

    make a tentative diagnosis of toxoplasmosis. CSF cy-

    tology may show a mixed pleocytosis (usually non-

    suppurative, although neutrophils may be present

    also). Protein in CSF may be normal to moderately el-

    evated.

    The treatment of choice for toxoplasmosis is either

    clindamycin or trimethoprim-sulfadiazine with

    pyrimethamine (Table 2). Although clindamycin is

    usually better tolerated by cats, its penetration of the

    intact blood-brain and blood-CSF barriers is

    marginal at best. In human studies, clindamycin did

    not cross the blood-brain barrier even if meningitis

    was present. Despite this finding, clindamycin is ad-

    vocated for use in feline CNS toxoplasmosis at 25

    mg/kg every 12 hours for 4 to 6 weeks.18 The author

    has recently used clindamycin in an infected cat

    (positive CSF titers) with CNS signs. Clinical signs

    disappeared while the cat was treated with the drug.

    When the drug was discontinued, the cats clinical

    signs returned in 4 to 8 weeks. Trimethoprim-

    sulfadiazine at 15 to 30 mg/kg every 12 hours for 3

    to 4 weeks with or without pyrimethamine (0.51.0

    mg/kg/day orally for 710 days) may also be effec-tive. This drug combination may cause signs of nau-

    sea and salivation in cats and also has the potential

    of producing bone marrow suppression. Folic acid

    supplementation (1 mg/kg orally every 24 hours) is

    recommended for cats on long-term sulfadiazine/

    pyrimethamine therapy.18,19

    Feline Infectious PeritonitisThe FIP virus (dry form) can cause a granulomatous

    to pyogranulomatous inflammation of the meninges,

    ependyma (ventricular linings) and subependymal tis-

    Table 2

    Antimicrobial Drugs for Central Nervous System Infections in Cats

    BBB Bactericidal vs Frequency

    Drug Target Pathogen(s) Penetration Bacteriostatic Dose (mg/kg) Route (hours)

    Amphotericin B Cryptococcus spp./other fungi Poor Static 0.150.5 (in 5% IV 48dextrose in water)

    Ampicillin Bacteria Intermediate Cidal 1020 IV 6Cefotaxime Bacteria Good Cidal 2550 IV or IM 8

    Ceftriaxone Bacteria Good Cidal 20 IV 12

    Cephalexin Bacteria Poor Cidal 1030 PO 8

    Chloramphenicol Bacteria/ Rickettsia spp. Good Static 1525 PO 12

    Clavamox Bacteria Poor Cidal 1020 PO 812

    Clindamycin Toxoplasma spp. Poor Static 12.525 PO 12

    Doxycycline Bacteria/ Rickettsia spp. Intermediate Static 2.55.0 PO 12

    Enrofloxacin Bacteria/ Rickettsia spp. Intermediate Cidal 2.55.0 PO 12

    Fluconazole Cryptococcus spp./other fungi Good Static 510 PO 12

    Flucytosine Cryptococcus spp./other fungi Good Static 2550 PO 68

    Gentamicin Bacteria Poor Cidal 2.04.0 IV or IM 8

    Itraconazole Cryptococcus spp./other fungi Poor Static 5 PO 1224

    Ketoconazole Cryptococcus spp./other fungi Poor Static 510 PO 812Metronidazole Bacteria (anaerobic) Good Cidal 25 PO 1224

    Penicillin G Bacteria Intermediate Cidal 20,00040,000 IV 6units/kg

    Pyrimethamine Toxoplasma spp. Good Cidal 0.51.0 PO 24

    Tetracycline Bacteria/ Rickettsia spp. Poor Static 1520 PO 8

    Trimethoprim- Toxoplasma spp./bacteria Good Cidal 1530 PO 12sulfadiazine

    BBB = blood-brain barrier; IM = intramuscularly; IV = intravenously; PO = per os.

  • 8/3/2019 62107289 Advances in Feline Neurology (1)

    6/8

    sues, and choroid plexus. Central vestibular signs are

    the most common neurologic signs seen with FIP

    virus infection of the CNS. Feline infectious peritoni-

    tis virus is also a common cause of seizures in cats

    less than 1 year of age. Hyperesthesia and caudal

    paresis may be seen with spinal cord involvement. A

    secondary hydrocephalus (with dullness, blindness,etc.) can occur because of obstruction of the fourth

    ventricle by fibrinous exudate and pyogranulomatous

    tissue. A cavernous sinus syndrome with a unilater-

    al fixed pupil, ophthalmoplegia, and absent ocular

    sensation has recently been seen with FIP infection of

    the forebrain in cats.9 FIP is primarily found in very

    young cats, and clinical signs are more likely to occur

    after repeated exposure to the virus. Ocular signs,

    fever, weight loss, and anorexia often accompany

    CNS signs. A definitive diagnosis of FIP can be made

    only by finding pyogranulomatous inflammation in

    multiple tissues at necropsy.57 A tentative diagnosis issupported by high coronavirus titers and a CSF tap

    that shows a neutrophilic pleocytosis (some mono-

    nuclear inflammation also may be seen) and a very el-

    evated protein content (often greater than 200 mg/dl).

    Coronavirus titers may be negative in some affected

    cats.57 Recently, molecular techniques (probes gener-

    ated against FIV RNA in leukocytes and probes gen-

    erated by polymerase chain reaction against smaller

    viral nucleotides) are showing some promise for

    definitive diagnosis of virulent FIP strains. There is

    no effective treatment for CNS FIP. Prednisone and

    other immunosuppressive/immunomodulatory therapy

    may help in the short term, but the disease is invari-

    ably progressive and ultimately fatal. Some vaccines

    have shown some efficacy in protection against exper-

    imental FIP challenge in cats, but efficacy against nat-

    ural exposure requires further study.

    Peripheral Vestibular DiseaseCauses of peripheral vestibular problems in cats in-

    clude idiopathic vestibular syndrome, inflammatory

    polyps, otitis (mites/bacteria), and middle and inner

    ear neoplasia (ceruminous gland adenocarcinoma andsquamous cell carcinoma are the most common). In-

    fections or mass lesions of the middle and inner ear

    may produce vestibular signs (head tilt, ataxia with or

    without nystagmus), cranial nerve VII signs (facial

    paralysis), and Horners syndrome.

    Idiopathic feline vestibular syndrome is the most

    common cause of peripheral vestibular signs in cats.

    Only vestibular signs are present and these signs may

    be severe (pronounced head tilt, rolling, falling, rotary

    or horizontal nystagmus with fast phase away from

    the side of the lesion). This disorder is usually seen in

    the late summer or early fall and, like FIE, coincides

    with the time of year when Cuterebra larvae are abun-

    dant. Peracute signs are usually self-limiting over 3 to

    7 days with no treatment. Supportive care (nutritional

    support, intravenous or subcutaneous fluids, etc.) may

    be necessary if anorexia, vomiting, or both accompa-

    ny the vestibular signs.

    Spinal Cord DiseasesSpinal cord diseases in cats are relatively uncom-

    mon compared to the dog. Intervertebral disk hernia-

    tion can occur in cats, but clinical disease is extremely

    rare. More common causes of spinal cord injury in-

    clude trauma, infectious meningomyelitis (as from

    toxoplasmosis, cryptococcosis, FIP), lymphosarcoma,

    and other neoplastic processes. Recently, vaccine-

    associated fibrosarcomas have been identified that

    have invaded the spinal canal and spinal cord follow-

    ing surgical excision from subcutaneous and musculartissues. Spinal radiographs, CSF analysis, serum and

    CSF titers, and sometimes myelography or MRI are

    indicated in a cat with spinal cord signs. This author

    recommends myelography if CSF analysis is normal

    and an extradural lesion is suspected. MRI is pre-

    ferred if an intramedullary lesion is suspected.

    Intramedullary lesions in cats include infectious

    myelitis (inflammation of the cord parenchyma itself),

    intradural lymphosarcoma, and intramedullary glial

    tumors (gliomas).

    Treatment guidelines depend on the underlying

    cause. Spinal cord lymphosarcoma carries a poor

    prognosis, but temporary remission of clinical signs

    can sometimes be achieved with chemotherapy.20

    Cobalt 60 teletherapy may also provide some benefit

    if used in conjunction with chemotherapy. Combined

    therapy may provide remission of clinical signs in

    many cats, but relapses often occur within 6 months

    of onset of treatment.20 FeLV status should be checked

    because prognosis and response to therapy tend to be

    poorer in FeLV-positive cats.

    If trauma (vertebral fracture/luxation or a traumatic

    disk) is the source of injury, medical therapy is indi-cated and surgical decompression and stabilization

    may be necessary. The cat served as one of the major

    animal models of spinal cord injury in the mid to late

    1980s, and methylprednisolone sodium succinate

    (MPSS, or Solu-Medrol [Pharmacia & Upjohn])

    therapy trials were attempted in cats during this time.

    Solu-Medrol was shown to be effective for spinal

    trauma if administered at 30 mg/kg within several

    hours of the trauma.21 Subsequent doses of 15 mg/kg

    at 2 hours and 6 hours followed by a constant rate in-

    fusion at 2.5 mg/kg/hour for 24 to 48 hours also im-

    ADVANCES IN FELINE NEUROLOGY 93

  • 8/3/2019 62107289 Advances in Feline Neurology (1)

    7/8

    94 PROCEEDINGS OF THE 23rd WALTHAM/OSU SYMPOSIUM

    proved outcome. The primary mechanism of action of

    MPSS is its ability to scavenge free radicals and pre-

    vent lipid peroxidation of cell membranes.21 The lim-

    iting factor is that this drug is effective only if admin-

    istered within hours of injury. Its use beyond 6 to 8

    hours of injury probably provides little benefit.

    Motor Unit DisordersMotor unit diseases in cats are uncommon. My-

    opathies and neuropathies may occur but are often sec-

    ondary to metabolic or endocrine disorders. Acquired

    myasthenia gravis (MG) is found sporadically in cats, es-

    pecially in purebred or mixed Abyssinian and Somali

    breeds. This is an immune-mediated junctionopathy

    characterized by the presence of autoantibodies directed

    against the acetylcholine receptor on the muscle mem-

    brane. The typical clinical signs are development of a

    stiff, choppy gait with exercise, severe weakness and/or

    collapse, ventral neck flexion due to cervical muscleweakness, and weak palpebral reflexes.22,23 One cat de-

    scribed in the literature had signs of focal MG

    (dropped jaw and dysphagia due to focal cranial nerve

    involvement).24 Megaesophagus is also a common find-

    ing. The definitive test for acquired MG is the serum

    acetylcholine receptor antibody test, but because serum

    has to be sent to special laboratories that perform this

    test, there is often a significant time delay before results

    are known. Intravenous injection of edrophonium chlo-

    ride, a short-acting anticholinesterase drug, will alleviate

    clinical signs for a few minutes and is a provocative di-

    agnostic test for MG. According to one author, the re-

    sponse of cats to Tensilon (ICN) is not as predictable as

    it is in dogs.19 Repetitive nerve stimulation is quite reli-

    able, although other neuromuscular junction disorders

    (botulism, chronic organophosphate toxicity) can also

    cause a decremental response during stimulation. Treat-

    ment is directed at treating the immune-mediated disor-

    der with prednisone and/or other immunosuppressive

    agents. Concurrent treatment with long-acting anti-

    cholinesterase agents (pyridostigmine bromide at 0.53.0

    mg/kg orally every 8 to 12 hours) is also helpful in alle-

    viating the tetraparetic state. Cats have a greater sensitiv-ity to pyridostigmine bromide than do dogs, so starting at

    0.5 mg/kg and slowly titrating upward until a clinical re-

    sponse is seen is the most rational approach.19,24 My-

    asthenia gravis in the cat is often self-limiting, but signs

    can persist for months before clinical remission is

    achieved. Monitoring the serum acetylcholine receptor

    antibody titer is used as a gauge to decide when to start

    tapering immunosuppressive therapy.

    Feline Hyperesthetic SyndromeFeline hyperesthetic syndrome is a poorly under-

    stood disorder characterized by episodes of agitation,

    rippling of the thoracolumbar muscles, swishing of

    the tail, biting of the pelvic limbs and lumbosacral re-

    gion, vocalization, and often running frantically as if

    startled. Various explanations for this behavior have

    been proposed, including a psychic behavioral distur-

    bance, allergic skin disease, partial complex seizure,and true hyperesthesia due to focal spinal cord or

    nerve root disease. This author has attempted hypo-

    allergenic diets, serotonin reuptake inhibitor therapy

    (fluoxetine, tricyclic antidepressants, etc.), anti-

    epileptic drug therapy, and corticosteroid drug therapy

    with little success. Recently, the Neurology Service at

    The Ohio State University Veterinary Teaching Hospi-

    tal has identified EMG changes and pathologic alter-

    ations in epaxial muscles of affected cats. Abnormali-

    ties in muscle include the presence of inclusion bodies

    that resemble those found in inclusion body my-

    opathies of humans. Although the significance ofthese inclusions is as yet unknown, they may provide

    a clue to the etiology of this syndrome.

    CONCLUSIONSCats with signs of neurologic disease may be diffi-

    cult to diagnose because of problems inherent in per-

    forming a thorough neurologic examination and be-

    cause of the great number of acquired disorders that

    can affect cats. Localization of the lesion(s) to specific

    compartments of the nervous system helps to narrow

    down the list of differential diagnoses, but, ultimately,

    extensive ancillary diagnostic testing is required to de-

    termine the etiologic basis of the clinical signs.

    Considerable progress has been made recently in

    the diagnosis and therapy of CNS cryptococcosis and

    toxoplasmosis. Clearly, understanding the long-term

    efficacy of many antimicrobial agents in the treatment

    of CNS infections is an area of weakness. On the oth-

    er hand, therapy for other disorders (epilepsy, spinal

    trauma, neoplasia, myasthenia gravis, etc.) has ex-

    panded dramatically in the last decade and many

    treatment options are available. Greater knowledge of

    the dynamic interplay between the CNS and the sys-temic response to injury is critical for the develop-

    ment of rational therapeutic strategies for feline ner-

    vous system disease in the future.

    REFERENCES1. Spodnick GJ, Berg J, Moore FM, Cotter SM: Spinal lymphoma in cats: 21 cases

    (19761989).JAVMA 3:373376, 1992.

    2. Malik R, Wigney DI, Muir DB, et al: Cryptococcosis in cats: Clinical and my-

    cological assessment of 29 cases and evaluation of treatment using orally ad-

    ministered fluconazole.J Med Vet Mycol 30:133144, 1992.

    3. Jacobs GJ, Medleau L, Calvert C, Brown J: Cryptococcal infection in cats: Fac-

    tors influencing treatment outcome, and results of sequential serum antigen

    titers in 35 cats.J Vet Intern Med11:14, 1997.

    4. Flatland B, Greene RT, Lappin MR: Clinical and serologic evaluation of cats

  • 8/3/2019 62107289 Advances in Feline Neurology (1)

    8/8

    with cryptococcosis.JAVMA 209:11101113, 1996.

    5. Baroni M, Heinhold Y: A review of the clinical diagnosis of feline infectious

    peritonitis viral meningoencephalomyelitis. Prog Vet Neurol 6:8894, 1995.

    6. Munana KR: Encephalitis and meningitis. Vet Clin North Am Small Anim Pract

    26:857873, 1996.

    7. Weiss RC: Feline infectious peritonitis and other coronaviruses, in Sherding RG

    (ed): The Cat: Diseases and Clinical Management, ed 2. New York, Churchill

    Livingstone, 1994, pp 449477.

    8. Glass E, de Lahunta A, Kent M, et al: A cryptococcal granuloma in the brain of

    a cat causing focal signs. Prog Vet Neurol 7:141144, 1996.9. Fenner WR: Diseases of the brain, spinal cord, and peripheral nerves, in Sherd-

    ing RG (ed): The Cat: Diseases and Clinical Management, ed 2. New York,

    Churchill Livingstone, 1994, pp 15071567.

    10. Glass E, Cornetta AM, de Lahunta A, et al: Clinical and clinicopathologic fea-

    tures in 11 cats with Cuterebra larvae myiasis of the central nervous system. J

    Vet Intern Med12:365368, 1998.

    11. Nafe LA: Meningiomas in cats: A retrospective clinical study of 36 cases.

    JAVMA 174:12241227, 1979.

    12. Schrader SC: Neurosurgery, in Sherding RG (ed): The Cat: Diseases and Clini-

    cal Management, ed 2. New York, Churchill Livingstone, 1994, pp 15771598.

    13. Lawson DC, Burk RL, Prata RG: Cerebral meningioma in the cat: Diagnosis

    and surgical treatment of ten cases. JAAHA 20:333342, 1984.

    14. Podell M: Antiepileptic drug therapy. Clin Tech Small Anim Pract13:185192,

    1998.

    15. Boothe DM: Anticonvulsant therapy in small animals. Vet Clin North Am Small

    Anim Pract28:411448, 1998.

    16. George K, Boothe DM, Nguyen J, Legrange S: Disposition of bromide in cats

    following oral administration of the potassium salt . San Antonio, Proc 14th

    ACVIM Forum, 1996, p 757.

    17. Hughes D, Moreau RE, Overall KL, Van Winkle TJ: Acute hepatic necrosis and

    liver failure associated with benzodiazepine therapy in six cats, 19861995. J

    Vet Emergency Crit Care 6(1):1320, 1996.

    18. Lappin MR: CVT update: Feline toxoplasmosis, in Bonagura JD (ed): Kirks

    Current Veterinary Therapy XII: Small Animal Practice. Philadelphia, WBSaunders, 1995, pp 309314.

    19. Cuddon PA: Feline neuromuscular diseases, in Kirk RW, Bonagura JD (eds):

    Current Veterinary Therapy XI: Small Animal Practice. Philadelphia, WB

    Saunders, 1992, pp 10241031.

    20. Couto CG, Hammer AS: Oncology, in Sherding RG (ed): The Cat: Diseases and

    Clinical Management, ed 2. New York, Churchill Livingstone, 1994, pp 755818.

    21. Hall ED: Review Article: The neuroprotective pharmacology of methylpred-

    nisolone.J Neurosurg 76:1322, 1992.

    22. Joseph RJ, Carrillo JM, Lennon VA: Myasthenia gravis in the cat.J Vet Intern

    Med2:7579, 1988.

    23. Indrieri RJ, Creighton SR, Lambert EH, Lennon VA: Myasthenia gravis in two

    cats.JAVMA 182:5760, 1983.

    24. Shelton GD: Disorders of neuromuscular transmission. Semin Vet Med Surg

    Small Anim 4:126132, 1989.

    ADVANCES IN FELINE NEUROLOGY 95